Reuters logo
BRIEF-Boehringer Ingelheim says FDA expands approval of SPIRIVA RESPIMAT spray
February 16, 2017 / 1:19 PM / 10 months ago

BRIEF-Boehringer Ingelheim says FDA expands approval of SPIRIVA RESPIMAT spray

Feb 16 (Reuters) - Boehringer Ingelheim -

* FDA expands approval of SPIRIVA RESPIMAT (tiotropium bromide) inhalation spray for maintenance treatment of asthma in children

* Boehringer Ingelheim - U.S. FDA approved SPIRIVA RESPIMAT for long-term, once-daily maintenance treatment of asthma in people age 6 and older Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below